The company’s consistent all-around performance was a major factor in the decision to buy shares in March 2018, and it’s a big reason why we have chosen to nearly double our stake in the company.
This is a high-quality company that has positioned itself very well to take advantage of a number of major trends in healthcare. Excellent fundamentals, a 3%+ yield, a moderate payout ratio, almost a decade of dividend raises, double-digit long-term dividend growth, and the potential that shares are 26% undervalued are all reasons why dividend growth investors should take a strong look at this stock.
This company runs a very simple business model that provides a necessary and ubiquitous service to millions of people. With a 5%+ yield, a reasonable payout ratio, almost 20 consecutive years of dividend raises, and the potential that shares are 9% undervalued, this is a rare high-yield dividend growth stock that looks undervalued in today’s market.
This is a high-quality company with excellent fundamentals across the board. More than 40 consecutive years of dividend increases, a 3%+ yield, double-digit long-term dividend growth, a low payout ratio, and the potential that shares are 18% undervalued are all great reasons to consider this stock right now.
This is a high-quality company with excellent fundamentals. Its diversification, depth, and breadth in terms of the geographic exposure, industry mix, and client base is incredible. The stock offers a ~3.5% yield, payout ratio below 50%, and 10 consecutive years of dividend raises. With shares potentially 13% undervalued, dividend growth investors should take a good look at this compelling long-term investment opportunity.